Overview

Biomarkers in Patients With Head and Neck Cancer

Status:
Completed

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

Summary

RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is studying biomarkers in patients with head and neck cancer.

Details

Lead Sponsor:

Eastern Cooperative Oncology Group
ECOG-ACRIN Cancer Research Group

Collaborator:

National Cancer Institute (NCI)

Treatments:

Cetuximab